Paid Clinical Trials Montpelier
Discover 180 paid clinical trials in Montpelier, Vermont. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyPrevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Sponsor:
Ensoma
Location:
Code:
NCT06605378
Conditions
Chronic Granulomatous Disease (CGD)
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Loratadine with PegfilgrastimEvaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain
Sponsor:
University of Vermont
Location:
Code:
NCT01311336
Conditions
Pegfilgrastim-induced Back and Leg Pain
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Loratadine
placebo
CDDP/TXT & ChemoradiationNeoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer
Sponsor:
University of Vermont
Location:
Code:
NCT00982436
Conditions
Head and Neck Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Docetaxel/cisplatin
Radiotherapy
Carboplatin
BiomarkersUsing Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT04462406
Conditions
Advanced Melanoma
Clinical Stage III Cutaneous Melanoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Melanoma of Unknown Primary
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ipilimumab
Nivolumab
Patient Observation
Pembrolizumab
Regional RadiotherapyRegional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT03488693
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 35+
Healthy Volunteers: Not accepted
Interventions
Radiation
No Radiation
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Radiation Therapy with AtezolizumabTesting the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04402788
Conditions
Extensive Stage Lung Small Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Atezolizumab
Biospecimen Collection
Computed Tomography
Magnetic Resonance Imaging
Positron Emission Tomography
RelugolixTesting the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
Sponsor:
NRG Oncology
Location:
Code:
NCT05053152
Conditions
Oligometastatic Prostate Carcinoma
Prostate Adenocarcinoma
Prostate Ductal Adenocarcinoma
Prostate Intraductal Carcinoma
Stage IVB Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Scan
Computed Tomography
Fluciclovine F18
Magnetic Resonance Imaging
Nivolumab with Usual TreatmentAdding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT06203600
Conditions
Advanced Esophageal Adenocarcinoma
Advanced Gastric Adenocarcinoma
Advanced Gastroesophageal Junction Adenocarcinoma
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
Clinical Stage III Esophageal Adenocarcinoma AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Magnetic Resonance Imaging
Nivolumab
Paclitaxel
Darolutamide & Hormone TherapyTwo Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
Sponsor:
NRG Oncology
Location:
Code:
NCT05050084
Conditions
Prostate Adenocarcinoma
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bicalutamide
Buserelin
Darolutamide
Degarelix
Flutamide
Shorter Duration RadiationTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Sponsor:
NRG Oncology
Location:
Code:
NCT05946213
Conditions
Prostate Adenocarcinoma
Stage III Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Computed Tomography
External Beam Radiation Therapy
Magnetic Resonance Imaging
Quality-of-Life Assessment
Questionnaire Administration